Glyconics Inks Exclusive Licensing Deal with Swansea U for COPD Biomarker Detection | GenomeWeb

NEW YORK (GenomeWeb) – Glyconics announced today it has signed an exclusive licensing agreement with Swansea University for the use of infrared spectroscopy for the diagnosis of chronic obstructive pulmonary disease.

The technology developed at the university's College of Medicine uses non-invasive IR spectroscopy to easily and rapidly analyze patient sputum samples for proteins, nucleic acids, and other biomarkers that are characteristic of COPD.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.